Actively Recruiting
Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
Led by Amazentis SA · Updated on 2026-04-29
100
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
Sponsors
A
Amazentis SA
Lead Sponsor
P
Princeton Consumer Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
The objective of this study is to investigate the irritation and sensitization potential of 1 topically applied test article containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize method
CONDITIONS
Official Title
Human Skin Safety Testing of 1 Mitopure Topical Products Using a Human Repeat Insult Patch Test (HRIPT) in Healthy Volunteers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males or females 18 years of age or older (50% with sensitive skin)
- Completed written informed consent
- Female subjects agree to use an acceptable method of birth control (e.g. abstinence, condoms, hormonal birth control, IUD, tubal ligation, hysterectomy, bilateral oophorectomy, post-menopausal for at least one year or male partner vasectomy)
You will not qualify if you...
- Pregnancy or lactation
- Participation in a repeat insult patch test (RIPT) or follow-up work within the last month
- Current treatment by a physician for allergy unless physician consulted by Investigator and participation approved
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
PCR Corp
Manchester, United Kingdom, M13 0AF
Actively Recruiting
Research Team
B
Brad Currier, PhD
CONTACT
A
Anurag Singh, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here